Allogene Therapeutics, Inc.
USD2.22
+0.09 (+4.23%)
CEO
David D. Chang
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.15
Prev. Close
$2.13
Day Low
$2.13
Day High
$2.24
52W Low
$0.98
52W High
$4.46
Market Cap
$0.54B
Volume
14.64M
| 47,700 |
| $0.00 |
| 23 Jun 2026 | Kazam Joshua A | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | MESSEMER DEBORAH M. | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | Mayo Stephen | director | A-Award | Acquired | 144,400 | $2.00 |
| 23 Jun 2026 | SATO VICKI L | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | WITTE OWEN N. | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | Humer Franz B | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | Barrett Elizabeth A. | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Apr 2026 | Yoshiyama Annie | SVP, Finance | S-Sale | Disposed | 9,586 | $2.31 |